Jesus L. Algarra

Albacete, CM, ES 
Albacete, CM, ES 

Overview

Jesus Algarra practices practicing medicine in Albacete, Spain.

His clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Burkitt Lymphoma, and Mantle Cell Lymphoma (MCL).

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Albacete, CM, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized Phase III, Multicentre, Open Label Clinical Trial Comparing Azacitidine Plus Pevonedistat Versus Azacitidine in Older/Unfit Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Chemotherapy
A Randomized Phase III, Multicentre, Open Label Clinical Trial Comparing Azacitidine Plus Pevonedistat Versus Azacitidine in Older/Unfit Patients With Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Standard Induction Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drugs: Pevonedistat, Azacitidine
Study Phase: Phase 3

9 Total Publications

Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI study.
Impact of hematopoietic cell transplantation and quizartinib in patients with newly diagnosed FLT3-internal tandem duplication-negative acute myeloid leukemia: results from the QUIWI study.
Journal: Haematologica
Published: March 10, 2026

Frequently Asked Questions about Jesus L. Algarra

Is Jesus L. Algarra a top-rated expert for Acute Myeloid Leukemia (AML)?

MediFind is an objective health platform that identifies experts based on real-world data. Jesus L. Algarra is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jesus L. Algarra participate in research or clinical trials?

Yes. Jesus L. Algarra has published 9 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Jesus L. Algarra's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Algarra's expertise for a condition
ConditionClose
        View All 7 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile